Compugates Holdings (5037) Fair Value & Analysis
Technology · MY · Market cap 90.8M MYR
Fair value as of: Jun 26, 2026
Analysis
Compugates Holdings (5037) currently trades at 0.0150 MYR, while our model-based Fair Value estimate is 0.0143 MYR — implying the stock looks roughly 5.0% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Compugates Holdings Berhad, an investment holding company, engages in the trading, marketing, and distribution of imaging, information technology, and communication-based products in Malaysia. It operates in three segments: Trading and Services; Property Development; and Agriculture. The company also provides gaharu tea and derivatives; and engages in gaharu tree plantation, as well as general merchant activities. In addition, it is involved in the plantation, cultivation, inoculation, harvesting, distillation, and trading of the Gaharu trees; and development, promotion, and marketing of Gaharu trees, and other derivatives and by-products. In addition, the company engages in the land owning, property investment holding, and property development businesses; and trading and cultivating agricultural products. Compugates Holdings Berhad was founded in 1997 and is based in Petaling Jaya, Malaysia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Compugates Holdings (5037) undervalued?
What is the fair value of 5037?
What is the quality score of 5037?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.